Analysis of New Endoscopic Features and Variable Stiffness in Colonoscopy: Prospective Randomised Trial
ELUFIBLI
Prospective Randomised Trial to Analyse the Advantages of the New Virtual Chromoendoscopy Features and the Variable Stiffness in Connection With Our Colonoscopic Examinations
1 other identifier
observational
1,000
1 country
1
Brief Summary
The aim of the present study is to develop and evaluate a computer-based methods for automated and improved detection and classification of different colorectal lesions, especially polyps. For this purpose first, pit pattern and vascularization features of up to 1000 polyps with a size of 10 mm or smaller will be detected and stored in our web based picture database made by a zoom BLI colonoscopy. These polyps are going to be imaged and subsequently removed for histological analysis. The polyp images are analyzed by a newly developed deep learning computer algorithm. The results of the deep learning automatic classification (sensitivity, specificity, negative predictive value, positive predictive value and accuracy) are compared to those of human observers, who were blinded to the histological gold standard. In a second approach we are planning to use LCI of the colon, rather than the usual white light. Here, we will determine, whether this technique could improve the detection of flat neoplastic lesions, laterally spreading tumors, small pedunculated adenomas and serrated polyps. The polyps are called serrated because of their appearance under the microscope after they have been removed. They tend to be located up high in the colon, far away from the rectum. They have been definitely shown to be a type of precancerous polyp and it is possible that using LCI will make it easier to see them, as they can be quite difficult to see with standard white light.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2016
CompletedFirst Submitted
Initial submission to the registry
July 27, 2017
CompletedFirst Posted
Study publicly available on registry
July 31, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2018
CompletedJuly 10, 2019
July 1, 2019
2 years
July 27, 2017
July 9, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (7)
diagnostic value of the computer algorithm
diagnostic value of the computer algorithm (sensitivity, specificity, negative predictive value, positive predictive value, accuracy) \[ Time Frame: 10 months \] \[ Designated as safety issue: No \]
2 years
Number of detected serrated polyps
Number of Detected Proximal Serrated lesions, flat polyps and colorectal adenomas in proximal colon
2 years
Number of detected polyps
Quantity of total number of colorectal adenomas found in the colon during colonoscopy was recorded and compared.
2 years
the accuracy of the NICE (NBI International Colorectal Endoscopic) criteria using FICE versus BLI Eluxeo technology
the accuracy of the NICE criteria using FICE versus BLI Eluxeo technology without optical zoom for differentiating between the non-neoplastic and neoplastic histotypes in diagnoses with high-confidence on a video-library of 120 polyps reviewed by 5 experts. 5 experts will review pictures from a web-library of subcentimetric polyps removed and histologically verified and will assess each of the three NICE criteria (colour/vascularization/surface), and classify the lesion as neoplastic or non-neoplastic with low or high confidence.
2 years
Inter-observer agreement among the 5 experts
Inter-observer agreement among the 5 experts \[ Time Frame: up to 6 months \] \[ Designated as safety issue: No \] The inter-observer agreement, among the 5 experts, on the final diagnosis (neoplastic or non-neoplastic) and on each individual NICE criterion for each polyp will be determined by using K statistics.
2 years
Cecal intubation rate
The proportion of colonoscopy procedures resulting in successful intubation of the cecum.
2 years
Propofol need for deep sedation
The main efficacy parameter is the amount of Propofol used for deep sedation during colonoscopy, expressed as the mean for each group.
2 years
Secondary Outcomes (6)
diagnostic interobserver variability based on the computer algorithm
2 years
the accuracy of the NICE criteria using FICE versus BLI Eluxeo technology with 50x optical zoom for differentiating between the non-neoplastic and neoplastic histotypes
2 years
Comparison of accuracy of BLI and LCI pictures
2 years
Improvement of adenoma detection rate by using LCI imaging comparing with that under white endoscopy
2 years
Time-to-cecum
2 years
- +1 more secondary outcomes
Study Arms (2)
LCI out group
The whitdrawal of the colonoscop happen in LCI mode.
WL (white light) out group
The whitdrawal of the colonoscop happen in WL mode.
Eligibility Criteria
All adult patients who did not meet the exclusion criteria were included in the study
You may qualify if:
- The patient must sign, understand and provide written consent for the procedure.
- Undergoing colonoscopy at our endoscopy unit for any indication in Propofol deep sedation
- Intact colon and rectum
- ASA (American Society of Anesthesiology) risk class 1, 2 or 3
You may not qualify if:
- Patients with inflammatory bowel disease;
- Patients with poor bowel preparation; (Boston score \<4)
- Female patients with pregnancy;
- Patients with mechanical bowel obstruction;
- Patients with diverticulitis or toxic megacolon;
- Patients with a history of radiation therapy to abdomen or pelvis;
- Patients with a history of severe cardiovascular, pulmonary, liver or renal disease and high ASA (\>3) risk of propofol sedation;
- Personal history of coagulation disorders or use of anticoagulants;
- Patients who are currently enrolled in another clinical investigation in which the intervention might compromise the safety of the patient's participation in this study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bács Kiskun County and Teaching Hospital
Kecskemét, Nyiri Street 38, 6000, Hungary
Study Officials
- PRINCIPAL INVESTIGATOR
Laszlo Madacsy, MD,pHd
Bács Kiskun Coeunty Teaching Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
July 27, 2017
First Posted
July 31, 2017
Study Start
October 1, 2016
Primary Completion
September 30, 2018
Study Completion
September 30, 2018
Last Updated
July 10, 2019
Record last verified: 2019-07
Data Sharing
- IPD Sharing
- Will not share